Skip to main content

You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

Times are shown in your local time zone GMT
Speaker Profile Image

Dr David Mazer

Professional Bio

David Mazer, M.D. is a Professor in the Departments of Anesthesia and Physiology at the University of Toronto. He received his medical training at the University of Saskatchewan and worked as a family physician in Inuvik NWT (north of the arctic circle), Whakatane New Zealand, and Cudworth Saskatchewan before attending the University of Toronto to complete his residency in Anesthesia. He subsequently completed his fellowship training in cardiovascular anesthesia research at the University of California San Francisco and has been actively engaged in clinical practice and research in Cardiac anesthesia and Critical Care since 1987. He has previously been Associate Editor of the Canadian Journal of Anesthesia, Coordinator of Critical Care and Medical Director of CVICU at St. Michael's Hospital, and Vice-Chair for Research for the Department of Anesthesia at the University of Toronto. He currently is Chair of the Research Ethics Board of St. Michael’s Hospital and Unity Health Toronto. He has received both the Research Recognition Award and Gold Medal from the Canadian Anesthesiologists’ Society. 

Dr. Mazer’s translational research has focused on understanding mechanisms and improving outcomes in perioperative patients with cardiovascular disease. His research program focuses on perioperative blood conservation, cardiac physiology and perioperative organ protection. Dr. Mazer is the co-founder of the CardioLink Platform of Clinical Trials.  He has co-authored over 200 peer-reviewed publications, including practice guidelines and position statements related to perioperative transfusion and hemostasis from the Society of Thoracic Surgeons, Society of Cardiovascular Anesthesiologists and the Canadian Cardiovascular Society. He was a lead anesthesia investigator in the BART trial and is the principal investigator for TRICS III and TRICS IV, global studies of transfusion triggers in cardiac surgery.